Source: Annual Congress 2011 - Biomarkers in sarcoidosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Paone, M. Rulli, A. Belli, A. Propati, A. Sbrocca, S. D‘Antonio, A. Sebastiani, G. Puglisi, G. Galluccio, S. Batzella (Rome, Milan, Italy). Use of discriminant analysis to assess pulmonary functional worsening in patients with sarcoidosis by means of a panel of inflammatory markers. Eur Respir J 2011; 38: Suppl. 55, 4520

Member's Comments

No comment yet.

Related content which might interest you: Relationships between COPD assessment test score and pulmonary function tests or quantitative CT analysis in Japanese COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Gene-set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms Year: 2010 Correlation between physical activity and prognostic markers in patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 258s Year: 2002 Effectiveness of a panel of sputum markers in smokers with and without COPD to detect pulmonary progression towards functional impairment Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (1) 00096-2016; 10.1183/23120541.00096-2016 Year: 2017 Simultaneous analysis of clinical markers for predicting increased lung function fluctability in stable asthma Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 Hierarchy of common lung function parameters in diagnosing COPD using discriminant analysis Source: Annual Congress 2010 - New diagnostic approaches in respiratory function Year: 2010 Association of texture-based quantitative fibrotic patterns and pulmonary function test in a new validation set Source: Annual Congress 2011 - Functional lung and pulmonary arterial imaging Year: 2011 Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis Source: ERJ Open Res, 6 (4) 00347-2020; 10.1183/23120541.00347-2020 Year: 2020 18FDG-PET imaging detects inflammatory changes in pediatric cystic fibrosis patients after treatment for a pulmonary exacerbation Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections Year: 2010 Comparative analysis of routine biochemistry data and neurohormonal markers in patients with different forms of pulmonary hypertension Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010 Inflammatory markers in cystic fibrosis patients with different values of pulmonary function tests Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002 Pirfenidone dose-response in patients with idiopathic pulmonary fibrosis (IPF): A comprehensive analysis of outcomes in CAPACITY 2 Source: Annual Congress 2010 - New insights in the treatment of idiopathic pulmonary fibrosis Year: 2010 The use of FENO in COPD: the relationship to pulmonary function tests and its importance in differential diagnosis. Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients Source: Eur Respir J 2014; 44: 951-962 Year: 2014 Comparative evaluation of diagnosis methods in the patients with pulmonary sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 539s Year: 2006 Correlation of different thresholds in CT lung densitometry and pulmonary function tests in stable COPD patients Source: Annual Congress 2007 - Imaging modalities in asthma, COPD and emphysema Year: 2007